AMBALAL SARABHAI ENTERPRISES
|
The Current P/B Ratio of AMBALAL SARABHAI ENTERPRISES is 2.72.
Share Price | ₹48.8 | Feb 03,2025 |
Market Cap | ₹373.5 Cr | |
Book Value | ₹137.1 Cr | Mar2024 - Consolidated Results |
Price/Book | 2.72x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of AMBALAL SARABHAI ENTERPRISES
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹373.5 Cr] as on Feb 03,2025
(/) Book Value [ ₹137.1 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 2.72x ]
Thus, for AMBALAL SARABHAI ENTERPRISES , the investors are currently willing to pay '2.72 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of AMBALAL SARABHAI ENTERPRISES !
The chart below summarizes the trend in P/B Ratio of AMBALAL SARABHAI ENTERPRISES over the last five years.
Historical PB (Price/Book ) ratio chart of AMBALAL SARABHAI ENTERPRISES
PB Ratio Performance Analysis for AMBALAL SARABHAI ENTERPRISES
- AMBALAL SARABHAI ENTERPRISES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.21x.
- AMBALAL SARABHAI ENTERPRISES 's operated at median p/b ratio of 2.23x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AMBALAL SARABHAI ENTERPRISES 's p/b ratio peaked in Mar2020 at 3.26x.
- AMBALAL SARABHAI ENTERPRISES 's p/b ratio hit its five-year low in Mar2023 of 1.2x.
How does AMBALAL SARABHAI ENTERPRISES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
AMBALAL SARABHAI ENTERPRISES | 137.13 | 2.72 | 373.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.56 | 417,472.0 |
CIPLA LTD | 26,619.90 | 4.31 | 114,754.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.57 | 100,465.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.89 | 96,875.2 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.52 | 156,342.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.41 | 106,597.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.64 | 107,226.0 |
LUPIN LTD | 14,175.80 | 6.55 | 92,786.6 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.19 | 65,453.4 |
ABBOTT INDIA LTD | 3,658.73 | 15.10 | 55,256.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs AMBALAL SARABHAI ENTERPRISES 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.19x |
Max industry PB | 15.64x |
Median industry PB | 6.55x |
Average industry PB | 7.68x |
You may also like the below Video Courses